{"id":9597,"date":"2018-02-18T05:00:35","date_gmt":"2018-02-18T10:00:35","guid":{"rendered":"https:\/\/medicarereport.org\/?p=9597"},"modified":"2018-02-16T10:50:47","modified_gmt":"2018-02-16T15:50:47","slug":"summary-of-recent-and-proposed-changes-to-medicare-prescription-drug-coverage-and-reimbursement","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=9597","title":{"rendered":"Summary of Recent and Proposed Changes to Medicare Prescription Drug Coverage and Reimbursement"},"content":{"rendered":"

(By Juliette Cubanski for The Henry J. Kaiser Family Foundation)<\/p>\n

On February 9, 2018 the President signed into law the\u00a0Bipartisan Budget Act of 2018\u00a0(BBA of 2018), which included some provisions related to Medicare Part D prescription drug coverage. Just days later, on February 12, the Office of Management and Budget (OMB) released the President\u2019s\u00a0fiscal year (FY) 2019 budget, which also included\u00a0several proposals\u00a0related to Medicare Part D drug coverage and Part B drug reimbursement. This brief summarizes these recent and proposed changes. Budget estimates for provisions in the BBA of 2018 reflect the 10-year (2018-2027) effects as estimated by the\u00a0Congressional Budget Office. Budget estimates for proposals in the President\u2019s FY2019 budget reflect the 10-year (2019-2028) effects as estimated by\u00a0OMB.1 Continue reading report here…<\/a><\/p>\n

\"\"<\/a><\/p>\n

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Juliette Cubanski for The Henry J. Kaiser Family Foundation) On February 9, 2018 the President signed into law the\u00a0Bipartisan<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,6,15],"tags":[],"class_list":["post-9597","post","type-post","status-publish","format-standard","hentry","category-legislative-update","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9597"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9597\/revisions"}],"predecessor-version":[{"id":9598,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/9597\/revisions\/9598"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}